leisure time -WSS

leisure time

author：fashion 2025-09-30 16:25:00 - browse：8

BiTE Bridge — Illustration of a BiTE, Amgen's bispecific antibodies Amgen

In cancer immunotherapy these days, technology is advancing so fast that 2017’s buzzy new treatment may soon be passe: Only 18 months after approval of the first CAR-T, pharmaceutical companies and biotechs are already talking about next-generation cancer therapy.

Called bispecific antibodies, they’re being developed by some two dozen companies large and small, with a version cleverly branded as BiTEs already constituting 60 percent of Amgen’s oncology pipeline. The appeal: Bispecifics make the immune system kill tumor cells like first-gen immunotherapy, but, unlike the weeks it takes to laboriously manufacture CAR-Ts, they can start being infused almost as quickly as an oncologist can write a prescription.

“We’re very bullish” on BiTEs, said Dr. David Reese, head of R&D at Amgen, which has the only cancer-targeting bispecific approved for clinical use in the U.S. and 14 more in development, including for multiple myeloma, small cell lung cancer, glioblastoma, and other solid tumors. “We can generate a BiTE against any tumor antigen we want to go after.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： What will save rural psychiatry services? Higher Medicaid payments

focus

WSS

Dark money group runs ads on China biotech bill

Scientists successfully use ultrasound imaging to map brain activity

Prosthetic arm enables patients to feel the objects they grip

Adam's Biotech Scorecard: Do Sarepta's exon

iTeos Therapeutics debuts first data on TIGIT

10 states plan to sue EPA over standards for residential wood

focus

leisure time

entertainment

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Dobbs anniversary: the lost opportunity of abortion as health care

Focused ultrasound for uterine fibroids: an uphill battle

Medicare proposal to cover medical devices draws a mixed reaction

Prosthetic arm enables patients to feel the objects they grip

Medicare details structure of new drug price negotiation program

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

Novavax promises a turnaround & Lilly roils the obesity market

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

hotspot

Adam's Biotech Scorecard: Do Sarepta's exon

Trump pressured former Arizona governor to overturn 2020 election results: Sources

10 states plan to sue EPA over standards for residential wood

Prosthetic arm enables patients to feel the objects they grip

4 dead, 2 in stable condition in Philadelphia shooting: Police

Report: NIH

leisure time

focus

hotspot

explore